Synonyms Bladder Mixed Adenocarcinoma |
Introduction A variant of bladder adenocarcinoma that histologically consists of more than one growth pattern such as enteric, mucinous or signet ring types. |
Target |
Mechanism PDL1 inhibitors |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. United States |
First Approval Date01 May 2017 |
Target |
Mechanism PD-1 inhibitors |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. Japan |
First Approval Date04 Jul 2014 |
Mechanism AXL inhibitors [+10] |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. United States |
First Approval Date29 Nov 2012 |
Start Date01 Aug 2019 |
Sponsor / Collaborator ![]() [+8] |
Start Date13 May 2019 |
Sponsor / Collaborator |
Start Date10 Apr 2019 |
Sponsor / Collaborator [+1] |